Skopos Labs, Inc. Gilead Sciences, Inc. Transaction History

Skopos Labs, Inc.

$300 Million
Q3 2024

A detailed history of Skopos Labs, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 5,291 shares of GILD stock, worth $474,920. This represents 0.15% of its overall portfolio holdings.

Number of Shares

5,291

Holding current value

$474,920

% of portfolio

0.15%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $352,327 - $444,391	5,291 New	5,291 $443,000
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $428,409 - $485,827	5,847 New	5,847 $474 Million

Others Institutions Holding GILD

# of Institutions

1,924

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.87 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.4 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skopos Labs, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Skopos Labs, Inc. with notifications on news.

Account